Aspire Biopharma Holdings, Inc. ·

ASBPW 8-K 2026-09-29

Aspire Biopharma Holdings, Inc. (ASBPW) 8-K dated 2026-09-29 — accession 0001493152-26-044908. This URL is the filing, not the ASBPW hub.

Aspire Biopharma Holdings, Inc. (ASBPW) common stock listed on US.

Aspire Biopharma Holdings, Inc. filed a 8-K on 2026-09-29. Accession 0001493152-26-044908.

Cached items: 4.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ASBPW revenue for 2026-06-30 was $63.1K. Net income was -$1.3M. ASBPW currently screens at market cap $0.

Not investment advice. The ASBPW SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr